Investor Relations

Press Releases

02 Dec '21

Talis Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MENLO PARK, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care (the “Company”), announced that the

15 Nov '21

Talis Biomedical Announces Third Quarter 2021 Financial Results and Business Progress

Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific MENLO PARK, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment

15 Nov '21

Talis Biomedical Announces Appointment of Brian Blaser as President, Chief Executive Officer and Director

Veteran executive previously led Abbott's global diagnostics organization Kim Popovits, interim chief executive officer, to resume role as Director on the Board of Talis MENLO PARK, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to

08 Nov '21

Talis Biomedical Granted FDA Emergency Use Authorization (EUA) for COVID-19 Molecular Point-of-Care Test to Detect SARS-CoV-2

Authorized for use in a variety of healthcare and congregate settings, Talis One™ enables lab-quality results without the wait to detect or rule out COVID-19 in less than 30 minutes Talis One’s robust dual gene target design optimizes test sensitivity and inclusivity of variants including the

Excellence at the Point of Care

Corporate Profile

Stock Information

Press Releases

Recent Events

Kim Popovits

Interim Chief Executive Officer

Roger Moody

Chief Financial Officer

Douglas Liu

Chief Operating Officer

Rob Kelley

Chief Commercial Officer

Excellence at the Point of Care

Corporate Profile

Stock Information

Press Releases

Recent Events

Executive Team

Kim Popovits

Interim Chief Executive Officer

Roger Moody

Chief Financial Officer

Douglas Liu

Chief Operating Officer

Rob Kelley

Chief Commercial Officer